XML 76 R58.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment Data (Schedule of Net Sales from External Customers by Products) (Details)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 28, 2024
USD ($)
reportable_segment
Jun. 30, 2023
USD ($)
Jun. 28, 2024
USD ($)
reportable_segment
Jun. 30, 2023
USD ($)
Segment Reporting Information        
Net sales $ 514.3 $ 475.0 $ 982.1 $ 899.6
Number of Reportable Segments | reportable_segment 2   2  
Specialty Brands | Operating Segments        
Segment Reporting Information        
Net sales $ 274.5 280.1 $ 531.8 532.1
Specialty Generics        
Segment Reporting Information        
Net sales 239.8 194.9 450.3 367.5
Specialty Generics | Operating Segments        
Segment Reporting Information        
Net sales 239.8 194.9 450.3 367.5
Acthar | Specialty Brands        
Segment Reporting Information        
Net sales 117.7 116.8 220.5 198.8
Inomax | Specialty Brands        
Segment Reporting Information        
Net sales 66.4 76.9 136.6 159.6
Therakos immunotherapy | Specialty Brands        
Segment Reporting Information        
Net sales 67.2 62.9 125.4 121.6
Amitiza [Member] | Specialty Brands        
Segment Reporting Information        
Net sales 15.3 18.6 34.7 43.1
Other | Specialty Brands        
Segment Reporting Information        
Net sales 2.6 1.5 3.3 3.4
Opioids | Specialty Generics        
Segment Reporting Information        
Net sales 95.2 72.1 177.1 134.3
ADHD | Specialty Generics        
Segment Reporting Information        
Net sales 41.8 19.0 73.5 41.4
Addiction Treatment | Specialty Generics        
Segment Reporting Information        
Net sales 21.0 16.1 36.4 31.7
Other Generics | Specialty Generics        
Segment Reporting Information        
Net sales 3.6 2.4 5.1 4.2
Generics | Specialty Generics        
Segment Reporting Information        
Net sales 161.6 109.6 292.1 211.6
Controlled substances | Specialty Generics        
Segment Reporting Information        
Net sales 26.4 20.9 49.3 39.4
APAP | Specialty Generics        
Segment Reporting Information        
Net sales 47.3 59.8 99.0 106.2
Other API | Specialty Generics        
Segment Reporting Information        
Net sales 4.5 4.6 9.9 10.3
API | Specialty Generics        
Segment Reporting Information        
Net sales 78.2 85.3 158.2 155.9
Terlivaz | Specialty Brands        
Segment Reporting Information        
Net sales $ 5.3 $ 3.4 $ 11.3 $ 5.6